March 27th, 2013|
Omontys is an injectable drug used to treat anemia in kidney dialysis patients. The manufacturers recalled all lots of Omontys (peginesatide) following reports of serious and potentially fatal hypersensitivity and allergic reactions. These reactions have been reported in patients within 30 minutes of their first injections of the drug.
Immediately following the recall, the FDA issued an alert to healthcare providers citing 19 reports of anaphylaxis from U.S. dialysis centers, three of which resulted in death. (more…)